These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16381954)

  • 41. [Antisense nucleic acid therapy of influenza virus].
    Hatta T; Abe T; Takai K; Takaku H
    Nihon Rinsho; 1997 Oct; 55(10):2765-71. PubMed ID: 9360404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ODNBase--a web database for antisense oligonucleotide effectiveness studies. Oligodeoxynucleotides.
    Giddings MC; Matveeva OV; Atkins JF; Gesteland RF
    Bioinformatics; 2000 Sep; 16(9):843-4. PubMed ID: 11108708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. siRNA Selection Server: an automated siRNA oligonucleotide prediction server.
    Yuan B; Latek R; Hossbach M; Tuschl T; Lewitter F
    Nucleic Acids Res; 2004 Jul; 32(Web Server issue):W130-4. PubMed ID: 15215365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.
    Kraemer K; Fuessel S; Schmidt U; Kotzsch M; Schwenzer B; Wirth MP; Meye A
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3794-800. PubMed ID: 14506173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
    Bertram J; Killian M; Brysch W; Schlingensiepen KH; Kneba M
    Biochem Biophys Res Commun; 1994 Apr; 200(1):661-7. PubMed ID: 7909438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure of translation initiation region of c-myc mRNA and thermostability of the c-myc mRNA/antisense ODN complex.
    Tanaka T; Kurihara Y; Sakamoto T; Furusawa M; Kobayashi A; Katahira M; Takeuchi K; Sugimoto N; Uesugi S
    Nucleic Acids Symp Ser; 1995; (34):135-6. PubMed ID: 8841589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of liposomal antisense oligonucleotides on mRNA and protein levels of the HPV 16 E7 oncogene.
    Lappalainen K; Pirilä L; Jääskeläinen I; Syrjänen K; Syrjänen S
    Anticancer Res; 1996; 16(5A):2485-92. PubMed ID: 8917339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effective intracellular delivery of oligonucleotides in order to make sense of antisense.
    Shi F; Hoekstra D
    J Control Release; 2004 Jun; 97(2):189-209. PubMed ID: 15196747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficient delivery of intact phosphodiester oligonucleotides by poly-beta-amino esters.
    Remaut K; Symens N; Lucas B; Demeester J; De Smedt SC
    J Control Release; 2010 May; 144(1):65-74. PubMed ID: 20114066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IDT SciTools: a suite for analysis and design of nucleic acid oligomers.
    Owczarzy R; Tataurov AV; Wu Y; Manthey JA; McQuisten KA; Almabrazi HG; Pedersen KF; Lin Y; Garretson J; McEntaggart NO; Sailor CA; Dawson RB; Peek AS
    Nucleic Acids Res; 2008 Jul; 36(Web Server issue):W163-9. PubMed ID: 18440976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PFRED: A computational platform for siRNA and antisense oligonucleotides design.
    Sciabola S; Xi H; Cruz D; Cao Q; Lawrence C; Zhang T; Rotstein S; Hughes JD; Caffrey DR; Stanton RV
    PLoS One; 2021; 16(1):e0238753. PubMed ID: 33481821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries.
    Ho SP; Bao Y; Lesher T; Malhotra R; Ma LY; Fluharty SJ; Sakai RR
    Nat Biotechnol; 1998 Jan; 16(1):59-63. PubMed ID: 9447595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells.
    Miyagishi M; Hayashi M; Taira K
    Antisense Nucleic Acid Drug Dev; 2003 Feb; 13(1):1-7. PubMed ID: 12691531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and properties of bile acid phosphoramidites 5'-tethered to antisense oligodeoxynucleotides against HCV.
    Lehmann TJ; Engels JW
    Bioorg Med Chem; 2001 Jul; 9(7):1827-35. PubMed ID: 11425584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics.
    Mansoor M; Melendez AJ
    Gene Regul Syst Bio; 2008 Sep; 2():275-95. PubMed ID: 19787090
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Theoretical and experimental approaches to design effective antisense oligonucleotides.
    Sczakiel G
    Front Biosci; 2000 Jan; 5():D194-201. PubMed ID: 10702382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computational antisense oligo prediction with a neural network model.
    Chalk AM; Sonnhammer EL
    Bioinformatics; 2002 Dec; 18(12):1567-75. PubMed ID: 12490440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selection of antisense oligonucleotides based on multiple predicted target mRNA structures.
    Bo X; Lou S; Sun D; Shu W; Yang J; Wang S
    BMC Bioinformatics; 2006 Mar; 7():122. PubMed ID: 16526963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiolabelled oligonucleotides for imaging of gene expression with PET.
    Lendvai G; Estrada S; Bergström M
    Curr Med Chem; 2009; 16(33):4445-61. PubMed ID: 19835563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RNAInter v4.0: RNA interactome repository with redefined confidence scoring system and improved accessibility.
    Kang J; Tang Q; He J; Li L; Yang N; Yu S; Wang M; Zhang Y; Lin J; Cui T; Hu Y; Tan P; Cheng J; Zheng H; Wang D; Su X; Chen W; Huang Y
    Nucleic Acids Res; 2022 Jan; 50(D1):D326-D332. PubMed ID: 34718726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.